Literature DB >> 84675

Immunofluorescence studies of anti-T cell antibodies and T cells in systemic lupus erythematosus. Selective loss of brightly staining T cells in active disease.

A D Steinberg, L W Klassen, D R Budman, G W Williams.   

Abstract

Peripheral blood T cells from patients with systemic lupus erythematosus (SLE) and age- and sex-matched controls were studied by flow microfluorometry by using SLE anti-cell antibodies and fluorescein conjugated antibody to human IgM. Brightly staining cells were reduced in a number of patients with active SLE. Analysis of SLE T cells separated on a discontinuous stractin gradient indicated a preferential loss of cells, especially brightly staining cells, from one fraction. Quantitation of this phenomenon indicated that an average of greater than 90% of the brightly staining T cells from that fraction was lost in active SLE. This preferential loss of a subpopulation of T cells in patients with active SLE may be responsible for many of their immunologic abnormalities.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 84675     DOI: 10.1002/art.1780220203

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  11 in total

1.  Cirrhosis and hypergammaglobulinemia.

Authors:  J D Stobo
Journal:  Dig Dis Sci       Date:  1979-10       Impact factor: 3.199

Review 2.  Antibodies to CD45 and other cell membrane antigens in systemic lupus erythematosus.

Authors:  J B Winfield; P Fernsten; J Czyzyk; E Wang; J Marchalonis
Journal:  Springer Semin Immunopathol       Date:  1994

3.  Multiple overlapping homologies between two rheumatoid antigens and immunosuppressive viruses.

Authors:  A Douvas; S Sobelman
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

Review 4.  Lymphocytotoxic antibodies in SLE: a review of the literature.

Authors:  C Osman; A J Swaak
Journal:  Clin Rheumatol       Date:  1994-03       Impact factor: 2.980

5.  Antibodies to T cells in patients with systemic lupus erythematosus can induce antibody-dependent cell-mediated cytotoxicity against human T cells.

Authors:  S Kumagai; A D Steinberg; I Green
Journal:  J Clin Invest       Date:  1981-03       Impact factor: 14.808

6.  Studies of immune functions of patients with systemic lupus erythematosus. T-cell subsets and antibodies to T-cell subsets.

Authors:  T Sakane; A D Steinberg; J P Reeves; I Green
Journal:  J Clin Invest       Date:  1979-11       Impact factor: 14.808

7.  Immunoregulation in Sjögren's syndrome: influence of serum factors on T-cell subpopulations.

Authors:  H M Moutsopoulos; A S Fauci
Journal:  J Clin Invest       Date:  1980-02       Impact factor: 14.808

8.  Alterations in immunoregulatory T cell subsets in active systemic lupus erythematosus.

Authors:  C Morimoto; E L Reinherz; S F Schlossman; P H Schur; J A Mills; A D Steinberg
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808

9.  Studies of immune functions of patients with systemic lupus erythematosus: antibodies to desialized, rather than intact, T cells preferentially bind to and eliminate suppressor effector T cells.

Authors:  M Honda; T Sakane; A D Steinberg; H Kotani; T Tsunematsu; K Moriyama; M Fukase
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

10.  Autoantibody to an immunoregulatory inducer population in patients with juvenile rheumatoid arthritis.

Authors:  C Morimoto; E L Reinherz; Y Borel; E Mantzouranis; A D Steinberg; S F Schlossman
Journal:  J Clin Invest       Date:  1981-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.